Commentary
Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors
Catherine D. De Angelis, Jeffrey M. Drazen, Frank A. Frizelle, Charlotte Haug, John Hoey, Richard Horton, Sheldon Kotzin, Christine Laine, Ana Marušić, A. John P.M. Overbeke, Torben V. Schroeder, Hal C. Sox and Martin B. Van Der Weyden
CMAJ June 21, 2005 172 (13) 1700-1702; DOI: https://doi.org/10.1503/cmaj.050600
Catherine D. De Angelis
Jeffrey M. Drazen
Frank A. Frizelle
Charlotte Haug
John Hoey
Richard Horton
Sheldon Kotzin
Christine Laine
Ana Marušić
A. John P.M. Overbeke
Torben V. Schroeder
Hal C. Sox
Martin B. Van Der Weyden
Article Figures & Tables
Tables
In this issue
Article tools
Respond to this article
Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors
Catherine D. De Angelis, Jeffrey M. Drazen, Frank A. Frizelle, Charlotte Haug, John Hoey, Richard Horton, Sheldon Kotzin, Christine Laine, Ana Marušić, A. John P.M. Overbeke, Torben V. Schroeder, Hal C. Sox, Martin B. Van Der Weyden
CMAJ Jun 2005, 172 (13) 1700-1702; DOI: 10.1503/cmaj.050600
Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors
Catherine D. De Angelis, Jeffrey M. Drazen, Frank A. Frizelle, Charlotte Haug, John Hoey, Richard Horton, Sheldon Kotzin, Christine Laine, Ana Marušić, A. John P.M. Overbeke, Torben V. Schroeder, Hal C. Sox, Martin B. Van Der Weyden
CMAJ Jun 2005, 172 (13) 1700-1702; DOI: 10.1503/cmaj.050600
Related Articles
Cited By...
- Is this clinical trial fully registered?
- On bias and transparency in the development of influential recommendations
- Clarifying a misunderstanding on clinical trial registry
- Standards for pharmaceutical advertising in Canada
- Pourquoi devrait-on inscrire les etudes cliniques?
- Why should clinical trials be registered?